EXHIBIT 99.1 Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2 Highest in the Company's History International Cannabis Revenue Increased 71% in Q4 and 19% for the Fiscal Year; Canadian Cannabis Remained #1 by Revenue in the Fiscal Year; Global Cannabis Gross Margin Increased by ~700 Basis Points in the Fiscal Year 19% Re ...

Core Insights - Tilray Brands, Inc. reported a fiscal year net revenue of $821 million, with a constant currency revenue of $834 million, impacted by strategic decisions that affected revenue by $35 million [1][12] - The company achieved its second-highest consolidated adjusted EBITDA in history during Q4 [1] - International cannabis revenue surged by 71% in Q4 and 19% for the fiscal year, with Canadian cannabis maintaining the top revenue position [1][4] - Tilray Beverages and Tilray Wellness experienced revenue growth of 19% and 9%, respectively, for the fiscal year [1][11] Financial Performance - Fiscal year 2025 net revenue increased by 4% to $821.3 million compared to $788.9 million in the prior fiscal year [13] - Gross profit for the fiscal year rose by 8% to $240.6 million, with a gross margin of 29% [13] - Cannabis net revenue for fiscal 2025 was $249 million, down from $272.8 million in the previous year, primarily due to strategic margin preservation efforts [13][11] - Adjusted EBITDA for fiscal 2025 was $55 million, compared to $60.5 million in the prior fiscal year [13] Strategic Initiatives - The company is focusing on international growth, with a 19% increase in international cannabis revenue and a 112% growth in European cannabis revenue when excluding Australia [4][5] - Tilray has made strategic acquisitions in the beverage sector, acquiring four craft brands from Molson Coors to enhance its market presence [6] - The introduction of hemp-derived Delta-9 THC drinks in the U.S. is part of Tilray's strategy to innovate at the intersection of cannabis, beverages, and wellness [7] Balance Sheet and Liquidity - Tilray reported a strong balance sheet with $256 million in cash and marketable securities, and total debt repayments of approximately $100 million to date [2][8] - The net debt to trailing twelve months adjusted EBITDA ratio stands at 0.3x, indicating strong financial health [8] Future Outlook - For fiscal year 2026, the company expects adjusted EBITDA to be between $62 million and $72 million, representing growth of 13% to 31% compared to fiscal year 2025 [12][11] - The company anticipates significant growth opportunities in cannabis, beverage, and wellness sectors, particularly in Europe and emerging markets [3][4]

Core Insights - Breckenridge Distillery has launched Casa Breck Tequila, marking its entry into the tequila market, inspired by the traditions of Jalisco and the spirit of the Rockies [1][8] - The new tequila line includes Casa Breck Blanco and Casa Breck Reposado, crafted with hand-harvested blue agave and traditional Mexican techniques [2][8] Product Details - Casa Breck Blanco features flavors of cooked agave, vanilla, honey, and lemongrass, while Casa Breck Reposado offers notes of cooked agave, vanilla, caramel, oak, and black pepper spice [4] - The suggested retail prices are $32.99–$34.99 for Blanco and $37.99–$39.99 for Reposado, with each bottle being 750ml [5] Production and Heritage - The Reposado, Añejo, and Extra Añejo tequilas are aged in Breckenridge Bourbon Whiskey barrels located in Mexico, infusing the tequila with unique character [3] - Casa Breck aims to honor traditional tequila-making while exploring innovative flavors, blending the essence of the Rocky Mountains with the heritage of Jalisco [4][8] Company Background - Breckenridge Distillery, founded in 2008, is known for its award-winning spirits and is recognized as the "World's Highest Distillery" [9][10] - The distillery has received numerous accolades, including multiple awards at the World Whiskies Awards and the San Francisco World Spirits Competition [10]

In its upcoming report, Tilray Brands, Inc. (TLRY) is predicted by Wall Street analysts to post quarterly loss of -$0.03 per share, reflecting an increase of 25% compared to the same period last year. Revenues are forecasted to be $240.05 million, representing a year-over-year increase of 4.4%. Over the past month, Tilray Brands shares have recorded returns of +105.8% versus the Zacks S&P 500 composite's +5.9% change. Based on its Zacks Rank #3 (Hold), TLRY will likely exhibit a performance that aligns with ...

Group 1 - Alliance Global Partners has cut its price target for Tilray Brands (TLRY) stock by 25%, from $1 to $0.75 per share, citing softness in international cannabis and alcohol sales [1][3] - Despite the price target cut, Tilray's stock price increased by 15.8% as of 2:05 p.m. ET on Tuesday, indicating an unexpected investor reaction [1][3] - Tilray generates 25% of its revenue and 40% of its gross profit from alcoholic beverages, which is significant for its overall financial performance [3] Group 2 - Tilray has not reported a profit since 2018 and has never generated positive free cash flow (FCF) [4][5] - Analysts do not expect Tilray to become profitable before 2029, although there are forecasts for positive FCF in 2026 [5] - Given the company's historical performance, there is skepticism regarding its ability to achieve positive FCF in the near future, leading to a recommendation to sell the stock [5]

Industry Overview - The Canadian cannabis market is gaining investor attention as the U.S. cannabis industry continues to grow rapidly, with legal cannabis sales projected to reach nearly $39 billion in 2024 and potentially exceed $44 billion in 2025 [1] - Despite the growth, federal legalization in the U.S. remains stalled, but several states are advancing their own reform efforts, which is attracting interest in Canadian companies with U.S. exposure [1] Company Highlights - **Tilray Brands Inc. (TLRY)**: - Tilray has expanded significantly in the U.S., owning over 150 dispensaries in key markets like California and Michigan, and has diversified into the wellness and THC-infused beverage sectors [4][7] - The company reported a 13% increase in net revenue to $200 million, with its cannabis segment generating $61 million at a 40% gross margin, and a 132% year-over-year growth in the beverage segment [7] - Although Tilray posted a net loss, it narrowed that loss and achieved an adjusted EBITDA of $9 million, indicating improving fundamentals [7] - **Canopy Growth Corporation (CGC)**: - Canopy operates approximately 120 dispensaries in the U.S. and owns the vaporizer company Storz & Bickel, focusing on both recreational and medical markets [8][10] - The latest quarterly report showed net revenue of around C$66 million, a slight decrease from the previous year, but gross profit rose over 65% to achieve a 35% gross margin [10] - Canopy has cut its total debt by nearly 50% over the fiscal year, reflecting a strong focus on long-term sustainability and operational efficiency [10] - **Cronos Group Inc. (CRON)**: - Cronos has a growing presence in the U.S. with distribution deals supplying products to around 80 dispensaries, focusing on cannabinoid innovation [11][13] - The company reported net revenue of over $32 million, reflecting year-over-year growth, and gross profit rose to $13.7 million due to better cost management [13] - Cronos is investing in research and development to position itself for long-term success in the competitive U.S. market [13] Strategic Insights - The three Canadian cannabis companies—Tilray, Canopy Growth, and Cronos—are strategically expanding their U.S. footprint and improving financial health, making them key players to watch as U.S. legalization discussions continue [14]

Core Insights - Breckenridge Distillery has launched Mock One, a new line of non-alcoholic spirits crafted to deliver the complexity and depth of traditional spirits without alcohol [1][4][7] - Mock One is designed for health-conscious consumers and mindful drinkers, offering sophisticated options for crafted cocktails [3][4][7] Product Details - Mock One includes expressions inspired by whiskey, gin, tequila, and rum, featuring bold and nuanced flavor profiles [7] - The tasting notes for Mock One products include: - Mock One Whiskey: oak, cinnamon, vanilla bean, honey [6] - Mock One Gin: juniper, Meyer lemon, kaffir lime, lavender [6] - Mock One Tequila: agave, vanilla bean, honey capsaicin [6] - Mock One Rum: vanilla bean, brown sugar, cola nut, oak [6] Market Availability - Mock One is currently available in Colorado retailers and online nationwide, with plans for broader retail distribution this fall [4][7] Company Background - Breckenridge Distillery, founded in 2008, is known for its award-winning blended bourbon whiskey and has received numerous accolades, including nine Icons of Whisky awards [1][10][12]

Core Insights - Tilray Brands has experienced a significant decline in stock price, dropping over 99% from its peak of nearly $150 due to various industry challenges [1][2] - Recent stock performance shows a 55% increase in a one-month span, raising questions about potential long-term recovery driven by improved cash flow and regulatory changes [2] Financial Performance - The 12-month stock price forecast for Tilray is $1.92, indicating a potential upside of 204.23% from the current price of $0.63 [3] - The company has improved its cannabis gross margins to 41%, up from 33% a year earlier, and achieved an overall gross margin of 28% compared to 26% in the prior year [4] - Tilray has successfully reduced its debt, with levels now under 1x its trailing 12-month EBITDA [4][6] - Fiscal 2025 revenue estimates have been revised down to $850 million to $900 million from a previous range of $950 million to $1 billion [6] Regulatory Environment - There is optimism regarding potential regulatory changes under the second Trump administration, particularly the possible reclassification of cannabis by the DEA [7][8] - The rescheduling process for cannabis has faced delays, but may resume with the confirmation of a new DEA Administrator [8] Product and Market Expansion - Tilray has expanded its product lineup, including new summer cannabis products and a significant beverage portfolio acquired from Anheuser-Busch [9][10] - The company has received authorization from the Italian Ministry of Health to import and distribute proprietary medical cannabis flowers, enhancing its position in the European market [11]

Why One-Time Cannabis Darling Tilray Is Now High On Beer https://t.co/jmIGlbt96I https://t.co/jmIGlbt96I ...

Core Viewpoint - Tilray Brands, Inc. is set to release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, on July 28, 2025, after market close [1] Group 1: Financial Results Announcement - The financial results will be announced after market close on July 28, 2025 [1] - A live conference call and audio webcast will be held to discuss these results at 4:30 PM Eastern Time on the same day [2] Group 2: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on the cannabis, beverage, wellness, and entertainment industries, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in over 20 countries, offering comprehensive cannabis products, hemp-based foods, and craft beverages [3]